This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Amarin Pharmaceuticals Ireland Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by George Grandolfi in Cardiovascular Treatment
Introduction
George Grandolfi is an accomplished inventor based in Bedminster, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular-related diseases. His innovative work has led to the development of a unique pharmaceutical composition that combines eicosapentaenoic acid and statins.
Latest Patents
Grandolfi holds a patent for a pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof, along with a statin. This invention focuses on methods of using these compositions to treat or prevent cardiovascular-related diseases. The integration of polyunsaturated fatty acids with statins represents a promising advancement in cardiovascular therapy.
Career Highlights
George Grandolfi is associated with Amarin Pharmaceuticals Ireland Limited, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in the field has been instrumental in advancing research and development efforts aimed at improving patient outcomes.
Collaborations
[Section skipped due to space constraints.]
Conclusion
George Grandolfi's contributions to pharmaceutical innovations, particularly in cardiovascular treatment, highlight the importance of combining different therapeutic agents for enhanced efficacy. His work continues to pave the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile